Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01180920 · ClinicalTrials.gov registry record
The Importance of Periostin in Periodontal Health and Disease
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 22
- Enrollment target
NCT01180920: Completed study, sponsored by University of Michigan.
NCT01180920 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01180920 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
The goal of this study is to determine the clinical importance of Periostin in oral health and disease. The long-term goal will be to develop practical applications for the diagnosis, treatment, prevention and cure of human periodontal diseases.
Primary Outcome
Periostin levels from gingival crevicular fluid (GCF), saliva, serum and tissue will be analyzed in both health and disease. Total RNA and protein extracts will be isolated and utilized for relative quantitative measurements.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2011-06 |
| Est. Completion | 2013-02 |
What the finished NCT01180920 record still lists
NCT01180920 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01180920 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01180920 about?
NCT01180920 is a clinical study titled "The Importance of Periostin in Periodontal Health and Disease". The goal of this study is to determine the clinical importance of Periostin in oral health and disease. The long-term goal will be to develop practical applications for the diagnosis, treatment, prevention and cure of human periodontal diseases.
What is the current status of trial NCT01180920?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2011-06. Estimated completion is 2013-02.
Who is sponsoring clinical trial NCT01180920?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia